Twitter Beğeni Hilesi

🔔Abstract submission for #EHA2024 closes on March 1st. Take the opportunity to profile your work at this high visibility congress. Plus, accepted abstracts will be published in an official HemaSphere supplement.🤝

Excited to see this published in NEJM. Phase 2 results of REVIVE - studying the efficacy of the hepcidin mimetic, rusfertide in phlebotomy dependent patients with PV. #MPNSM. Phase 3 VERIFY study is ongoing. Naveen Pemmaraju, MD Aaron Gerds MD, MS Jeanne M Palmer Abdulraheem Yacoub Moffitt Cancer Center

From Bench to Bedside! Knowing the underlying biology and the importance of hepcidin in regulating iron homeostasis has brought benefit to patients with Polycythemia Vera! Have a look to the fresh publication on NEJM! nejm.org/doi/full/10.10…

We couldn’t agree more with Dr. Mohan Narla! #anaemia should be a global and #haematology research priority. The anaemia research laboratory WEHI (Walter and Eliza Hall Institute) is working on new ways to treat acquired and inherited anaemia across the world…

Pleased to share our latest: Haemoglobin thresholds to define anaemia from age 6 months to 65 years: estimates from international data sources - The Lancet Haematology thelancet.com/journals/lanha…

Interesting work! Published in HemaSphere Journal (IF = 12.1)

You are all invited to attend the virtual talk of Tracey Rouault on Iron Sulfur Proteins, within the Utah seminar series! cihd.cores.utah.edu/event/tracey-r…

Who is ready for the European Iron Club 2024? Happening next week in Toulouse, France. Get ready for awesome iron science! Che ci the program at the link below! eic2024.inviteo.fr/en/full-confer…

Check this out! Iron nanoparticles in lung tumor 🫁 treatment! Congrats to our very own Mamu and all I-authors!

BioIron Meeting 2025 #Announcement The BioIron Meeting 2025 in Montreal is just a year away! Make sure to submit an abstract and make plan for the meeting! We hope to see you ALL there!!

Visit the ⁦European Hematology Association⁩ Knowledge booth at #EHA2024 to learn more about ⁦HemaSphere Journal (IF = 12.1)⁩

Have a look into the latest translational study from the Lakhal-Littleton Lab! Prof Samira Lakhal-Littleton The study identifies the mechanisms through which IV iron therapy raises myocardial iron, and raises questions about the safety of long term IV iron therapy. academic.oup.com/eurheartj/adva…

Happy and proud of HemaSphere Journal (IF = 12.1) !!!! European Hematology Association

Listen to the new HemaSphere Podcast! Was such a pleasure to interview Alessandra Balduini on her science about platelets and silk-based bone marrow modeling! ⁦⁦HemaSphere Journal (IF = 12.1)⁩ ⁦European Hematology Association⁩ ⁦Francesca Vinchi⁩ youtube.com/watch?v=9QPo7m…

Transferrin: the iron transporter takes control ow.ly/4zX150Sw3Je #redcellsironanderythropoiesis

BioIron Social is launching its Podcast Series! The aims of the series is to introduce to the broader community research groups and labs working on iron, discuss about iron-related ‘hot’ topics, spread the world about iron conferences and meetings! Stay Tuned!

Big news within the BioIron Society! For the first time the BioIron has a Junior Board. Trainees researching in the iron field have been selected to join the Junior Board, which will organize educational events and initiatives for trainees! bioiron.org/about-us/junio…

The Iron Research Lab is looking for a motivated and talented PostDoctoral fellow to study aspects related to iron and macrophages in hematologic diseases! If interested, please send a CV to [email protected]

We have an open position in the lab! If you are interested in pursuing a PostDoc on hematology and iron in the vibrant scientific environment of NYBC and New York City, contact us!